Here's something you might be interested in.
Ask a Hipster — Advice you didn't know you needed
Big Screen — Movie commentary
Blurt — Music's inside track
Booze News — San Diego spirits
Classical Music — Immortal beauty
Classifieds — Free and easy
Cover Stories — Front-page features
Drinks All Around — Bartenders' drink recipes
Excerpts — Literary and spiritual excerpts
Feast! — Food & drink reviews
Feature Stories — Local news & stories
Fishing Report — What’s getting hooked from ship and shore
From the Archives — Spotlight on the past
Golden Dreams — Talk of the town
The Gonzo Report — Making the musical scene, or at least reporting from it
Letters — Our inbox
Movies@Home — Local movie buffs share favorites
Movie Reviews — Our critics' picks and pans
Musician Interviews — Up close with local artists
Neighborhood News from Stringers — Hyperlocal news
News Ticker — News & politics
Obermeyer — San Diego politics illustrated
Outdoors — Weekly changes in flora and fauna
Overheard in San Diego — Eavesdropping illustrated
Poetry — The old and the new
Reader Travel — Travel section built by travelers
Reading — The hunt for intellectuals
Roam-O-Rama — SoCal's best hiking/biking trails
San Diego Beer — Inside San Diego suds
SD on the QT — Almost factual news
Sheep and Goats — Places of worship
Special Issues — The best of
Street Style — San Diego streets have style
Surf Diego — Real stories from those braving the waves
Theater — On stage in San Diego this week
Tin Fork — Silver spoon alternative
Under the Radar — Matt Potter's undercover work
Unforgettable — Long-ago San Diego
Unreal Estate — San Diego's priciest pads
Your Week — Daily event picks
Will latest U-T deal replace reporters with robots?
Artificial intelligence and "machine vision" tied to Tribune's Soon-Shiong deal
Patrick Soon-Shiong
More twisting in the wind seems ahead for the besieged staff of the Union-Tribune as yet another Los Angeles billionaire joins the cast of characters on the big-money merry-go-round otherwise known as Chicago's Tribune Publishing.
As reported here last September, Patrick Soon-Shiong — called the wealthiest person in Los Angeles by the L.A. Business Journal, and part owner of the Lakers — has long been rumored to have his eye on the Tribune-owned L.A. Times, and sister Union-Tribune, which survives only through an umbilical cord to the Times printing plant in Los Angeles.
Among his other superlatives, Soon-Shiong, with an estimated net worth of $11.8 billion, has also been labeled "the world's richest doctor," according to Forbes.
Now he's getting into the newspaper business with Michael Ferro, the controversial master of Tribune, a move carrying high stakes for harried reporters who could lose their jobs to banks of artificial intelligence machines dreamed up by the South African–born surgeon.
In a deal intended by Ferro to ward off a hostile takeover bid by national newspaper giant Gannett, Soon-Shiong is buying 12.9 percent of Tribune Publishing for $15 a share, making the number of his 4.7 million–share stake in Tribune virtually tied with those of Oaktree Management of Los Angeles, which has roundly criticized Ferro's high-tech turnaround plan and urged a sale to Gannett.
On Monday (May 23), Tribune rejected Gannett's sweetened offer for the company and the putative takeover bid may be running out of steam, with Gannett saying it would wait for the results of Tribune's annual meeting June 2 — at which Gannett has asked shareholders to withhold their votes for boardmembers — before deciding what to do next.
“Tribune again changed the composition of its board without stockholder participation,” Gannett noted of Soon-Shiong's new title of vice-chairman under Ferro, the Wall Street Journal reported.
When not dabbling in sports and the future of the newspaper industry, Soon-Shiong operates an outfit called NantWorks.
"The company aims to connect all of a patient's health data and leverage it with genetic information to revolutionize the healthcare experience," says Forbes.
The super-rich physician also runs NantKwest, an L.A.-based start-up that opened a plant on Torrey Pines Mesa earlier this year.
"We're very excited about being in San Diego, because the talents, the skill sets around are fabulous," he told the U-T in March. "The manufacturing facility we acquired was ideal."
But what goes up in Soon-Shiong's biotech empire also goes down, as noted by the Motley Fool in February.
"Despite billionaire CEO Patrick Soon-Shiong outlining plans for a cancer moonshot program at the J.P. Morgan Healthcare Conference early last month, shares in Soon-Shiong's NantKwest toppled 40.6% in January," the website reported.
"January's sell-off shows just how risky these early stage biotech stocks can be."
As of early this week, NantKwest was trading around $6.50 a share, after a long fall from its peak of $34.99 soon after the company went public last July.
Another Soon-Shiong company, NantHealth, was sued for fraud by ex-employees who claimed the reliability of its systems were overrated and cash payments were used to attract federal funding, according to a January 2015 report in the New York Times.
Added the paper, "An investigation more than a decade ago by The New York Times found that a little-known drug company then headed by Dr. Soon-Shiong had a financial relationship with Premier, a major purchaser of supplies for hospitals nationwide that was supposed to be free of such conflicts."
Curing the cancer that is eating away at the Union-Tribune and the other newspapers in Tribune's troubled fold may pose an even tougher challenge for Soon-Shiong, but according to Forbes, he is ready and willing, even if that may mean replacing editors and reporters with robots.
"On Monday morning, Tribune Publishing and NantWorks entered a licensing agreement on over 100 machine vision and artificial intelligence technology patents for news media applications," reports Forbes.
"Tribune will also gain access to studio space made available by NantWorks subsidiary, NantStudio, LLC. In the license, Tribune will earn the first $80 million in revenues from NantWorks’s AI patents and a 6% royalty on revenues thereafter."
According to the account, "To effectuate this AI licensing plan, Tribune will issue 333,333 shares to NantStudio, worth roughly $5 million at current prices."
Said Soon-Shiong in a statement, "All industries go through cycles and Tribune, recognizing the vital role of technology in the future of publishing, is transitioning from a legacy newspaper company to a technology and content company…. I believe it is critical to our democracy and to our way of life that we have a strong, vibrant media and that it continues to function as the fourth estate.”
Here's something you might be interested in.
Will latest U-T deal replace reporters with robots?
Artificial intelligence and "machine vision" tied to Tribune's Soon-Shiong deal
Will latest U-T deal replace reporters with robots?
Artificial intelligence and "machine vision" tied to Tribune's Soon-Shiong deal
Patrick Soon-Shiong
More twisting in the wind seems ahead for the besieged staff of the Union-Tribune as yet another Los Angeles billionaire joins the cast of characters on the big-money merry-go-round otherwise known as Chicago's Tribune Publishing.
As reported here last September, Patrick Soon-Shiong — called the wealthiest person in Los Angeles by the L.A. Business Journal, and part owner of the Lakers — has long been rumored to have his eye on the Tribune-owned L.A. Times, and sister Union-Tribune, which survives only through an umbilical cord to the Times printing plant in Los Angeles.
Among his other superlatives, Soon-Shiong, with an estimated net worth of $11.8 billion, has also been labeled "the world's richest doctor," according to Forbes.
Now he's getting into the newspaper business with Michael Ferro, the controversial master of Tribune, a move carrying high stakes for harried reporters who could lose their jobs to banks of artificial intelligence machines dreamed up by the South African–born surgeon.
In a deal intended by Ferro to ward off a hostile takeover bid by national newspaper giant Gannett, Soon-Shiong is buying 12.9 percent of Tribune Publishing for $15 a share, making the number of his 4.7 million–share stake in Tribune virtually tied with those of Oaktree Management of Los Angeles, which has roundly criticized Ferro's high-tech turnaround plan and urged a sale to Gannett.
On Monday (May 23), Tribune rejected Gannett's sweetened offer for the company and the putative takeover bid may be running out of steam, with Gannett saying it would wait for the results of Tribune's annual meeting June 2 — at which Gannett has asked shareholders to withhold their votes for boardmembers — before deciding what to do next.
“Tribune again changed the composition of its board without stockholder participation,” Gannett noted of Soon-Shiong's new title of vice-chairman under Ferro, the Wall Street Journal reported.
When not dabbling in sports and the future of the newspaper industry, Soon-Shiong operates an outfit called NantWorks.
"The company aims to connect all of a patient's health data and leverage it with genetic information to revolutionize the healthcare experience," says Forbes.
The super-rich physician also runs NantKwest, an L.A.-based start-up that opened a plant on Torrey Pines Mesa earlier this year.
"We're very excited about being in San Diego, because the talents, the skill sets around are fabulous," he told the U-T in March. "The manufacturing facility we acquired was ideal."
But what goes up in Soon-Shiong's biotech empire also goes down, as noted by the Motley Fool in February.
"Despite billionaire CEO Patrick Soon-Shiong outlining plans for a cancer moonshot program at the J.P. Morgan Healthcare Conference early last month, shares in Soon-Shiong's NantKwest toppled 40.6% in January," the website reported.
"January's sell-off shows just how risky these early stage biotech stocks can be."
As of early this week, NantKwest was trading around $6.50 a share, after a long fall from its peak of $34.99 soon after the company went public last July.
Another Soon-Shiong company, NantHealth, was sued for fraud by ex-employees who claimed the reliability of its systems were overrated and cash payments were used to attract federal funding, according to a January 2015 report in the New York Times.
Added the paper, "An investigation more than a decade ago by The New York Times found that a little-known drug company then headed by Dr. Soon-Shiong had a financial relationship with Premier, a major purchaser of supplies for hospitals nationwide that was supposed to be free of such conflicts."
Curing the cancer that is eating away at the Union-Tribune and the other newspapers in Tribune's troubled fold may pose an even tougher challenge for Soon-Shiong, but according to Forbes, he is ready and willing, even if that may mean replacing editors and reporters with robots.
"On Monday morning, Tribune Publishing and NantWorks entered a licensing agreement on over 100 machine vision and artificial intelligence technology patents for news media applications," reports Forbes.
"Tribune will also gain access to studio space made available by NantWorks subsidiary, NantStudio, LLC. In the license, Tribune will earn the first $80 million in revenues from NantWorks’s AI patents and a 6% royalty on revenues thereafter."
According to the account, "To effectuate this AI licensing plan, Tribune will issue 333,333 shares to NantStudio, worth roughly $5 million at current prices."
Said Soon-Shiong in a statement, "All industries go through cycles and Tribune, recognizing the vital role of technology in the future of publishing, is transitioning from a legacy newspaper company to a technology and content company…. I believe it is critical to our democracy and to our way of life that we have a strong, vibrant media and that it continues to function as the fourth estate.”
Comments